USPTO serial 98169997
SIMTRA
Reviewed by CopyMark Law Group
Status 733Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- NGUYEN, CINDY EVANS
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with SIMTRA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,545*
Plus Government fees of $750
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
New York, NY, US
New York, NY, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Salima A. Merani
Salima A. Merani Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorIrvine, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, infectious diseases, immune disorders, infertility, viruses, blood disorders, genetic disorders, digestive disorders, inflammation, diabetes-related conditions, viral conditions, metabolic conditions, endocrine conditions, musculoskeletal conditions, cardiovascular conditions, cardiopulmonary conditions, genitourinary conditions, sexual dysfunction, hepatological conditions, ophthalmic conditions, respiratory conditions, gastrointestinal conditions, hormonal conditions, degenerative disorders, and dermatological conditions; Chemical additives for use in the manufacture of pharmaceuticals; Chemical additives for use in the manufacture of a wide variety of goods; Chemical preparations for scientific purposes; Chemicals for use in industry and science | ACTIVE | — |
| 005 | Dermatologicals; Inhalers for medical purposes, sold filled with pharmaceutical preparations for treating respiratory disorders, infectious disorders, infertility, viruses, diabetes-related conditions, cancer, immune conditions and inflammation; Medicated cosmetics; Medicated dermatological preparations and substances; Pharmaceutical preparations for the treatment and prevention of cancer, infectious diseases, immune disorders, infertility, viruses, blood disorders, genetic disorders, digestive disorders, inflammation, diabetes-related conditions, viral conditions, metabolic conditions, endocrine conditions, musculoskeletal conditions, cardiovascular conditions, cardiopulmonary conditions, genitourinary conditions, sexual dysfunction, hepatological conditions, ophthalmic conditions, respiratory conditions, gastrointestinal conditions, hormonal conditions, degenerative disorders and dermatological conditions; Syringes sold filled with pharmaceutical preparations for treating respiratory disorders, infectious disorders, infertility, viruses, diabetes-related conditions, cancer, immune conditions and inflammation | ACTIVE | — |
| 040 | Custom manufacture of pharmaceuticals; Manufacturing services for others in the field of pharmaceuticals; Providing technical information in the field of pharmaceutical manufacturing | ACTIVE | — |
| 042 | Consulting services in the field of pharmaceutical research and development; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Testing of pharmaceuticals | ACTIVE | — |
| 044 | Pharmaceutical advice; Pharmaceutical compounding services; Providing medical information to manufacturers in the form of reports in the field of manufacturing of active ingredients and scaling | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BAMBOO US BIDCO LLC
- Other trademarks owned by BAMBOO US BIDCO LLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SIMTRA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 14, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 13, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 13, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 13, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 28, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 27, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 27, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 27, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 8, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 7, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 7, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 7, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 4, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 4, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 4, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 3, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 13, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 18, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 18, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 29, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 13, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 3, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 20, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 7, 2023 | NWAP | NEW APPLICATION ENTERED | — |